Chemotherapy and targeted therapies in the era of check-point inhibitors

Date 18 December 2016
Event ESMO Asia 2016 Congress
Session Management of high risk urothelial cancer
Presenter Joaquim Bellmunt
Authors J. Bellmunt
  • Genitourinary Oncology, Dana-Farber Cancer Institute, 2215 - Boston, MA/US